Oral treatment with uracil-tegafur, etoposide and leucovorin in non-Asian patients with recurrent non-small cell lung cancer: A non-randomized, phase II study

被引：0
|
作者：
Surmont, V. F.
Aerts, J.
Pouw, E.
Vernhout, R. M.
Gras, E. J.
Tan, K. Y.
Hoogsteden, H.
van Klaveren, R.
机构：
[1] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[2] Amphia Hosp, Breda, Netherlands
[3] Groene Hartziekenhuis, Gouda, Netherlands
[4] St Franciscus Gasthuis, Rotterdam, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19019
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
    Abratt, RP
    Bezwoda, WR
    Goedhals, L
    Hacking, DJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1086 - 1086
  • [42] Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer
    Oshita, F
    Noda, K
    Nishiwaki, Y
    Fujita, A
    Kurita, Y
    Nakabayashi, T
    Tobise, K
    Abe, S
    Suzuki, S
    Hayashi, I
    Kawakami, Y
    Matsuda, T
    Tsuchiya, S
    Takahashi, S
    Tamura, T
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 304 - 309
  • [43] EXPLORATORY SUBGROUP ANALYSIS OF CRIZOTINIB EFFICACY AND SAFETY IN ASIAN AND NON-ASIAN PATIENTS WITH ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) ENROLLED IN A GLOBAL PHASE II STUDY
    Hida, Toyoaki
    Shi, Yuankai
    Ahn, M-J
    Liu, Xiaoquing
    Shaw, A. T.
    Yang, P-C
    De Pas, T. M.
    Han, J-Y
    Satouchi, M.
    Lanzalone, S.
    Polli, A.
    Kim, Dong-Wan
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S454 - S455
  • [44] Carboplatin oral etoposide personalised dosing in elderly non-small cell lung cancer patients
    Frasci, G
    Comella, P
    Panza, N
    De Cataldis, G
    Del Gaizo, F
    Pozzo, C
    Gravina, A
    Ruffolo, P
    Cioffi, R
    Marcatili, P
    Della Vittoria, M
    Monfardini, S
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (11) : 1710 - 1714
  • [45] Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study
    Gridelli, C
    Rossi, A
    Scognamiglio, F
    Guida, C
    Fiore, F
    Gatani, T
    Scoppa, G
    Pergola, M
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4755 - 4758
  • [46] A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer
    Rosell, R
    Felip, E
    Massuti, B
    GonzalezLarriba, JL
    Benito, D
    LopezCabrerizo, MP
    Salamanca, O
    Camps, C
    PuertoPica, J
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 56 - 60
  • [47] Cyclophosphamide and etoposide for non-small cell and small cell lung cancer
    Grunberg, SM
    DRUGS, 1999, 58 (Suppl 3) : 11 - 15
  • [48] Cyclophosphamide and Etoposide for Non-Small Cell and Small Cell Lung Cancer
    Steven M. Grunberg
    Drugs, 1999, 58 : 11 - 15
  • [49] Treatment of non-small-cell lung cancer with prolonged oral etoposide
    Kakolyris, S
    Samonis, G
    Koukourakis, M
    Vlachonicolis, I
    Chalkiadakis, G
    Kalbakis, K
    Souglakos, I
    Agelaki, S
    Toloudis, P
    Georgoulias, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (05): : 505 - 508
  • [50] Linifanib treatment in patients with non-small cell lung cancer (NSCLC): Phase II results
    Soo, R. A.
    Goss, G. D.
    Salgia, R.
    Besse, B.
    Gandara, D. R.
    Hanna, N. H.
    Ricker, J. L.
    Qian, J.
    Carlson, D. M.
    Tan, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345